Mycoremediation of Sulfamethoxazole and metabolic pathway by Aspergillus tubingensis strain.

IF 2 4区生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Biotechnology Letters Pub Date : 2025-02-05 DOI:10.1007/s10529-025-03568-6

Raveena Ann Alex, Jayanthi Abraham

{"title":"Mycoremediation of Sulfamethoxazole and metabolic pathway by Aspergillus tubingensis strain.","authors":"Raveena Ann Alex, Jayanthi Abraham","doi":"10.1007/s10529-025-03568-6","DOIUrl":null,"url":null,"abstract":"<p><p>Over the last few decades sulfonamides are being prescribed on a large scale for treating human beings and livestock. Contaminants of sulfonamide antibiotics are present in various environments and these residues can enter the food web, leading to health threat. The purpose of this study was to assess sulfamethoxazole degradation using a novel strain of Aspergillus sp. and demonstrates the degradation pathway of sulfamethoxazole. To the best of our knowledge, this marks the first detailed biodegradation pathway for Aspergillus sp. AJC4 proposed. The biodegradation pattern of sulfamethoxazole was assessed using High Performance Liquid Chromatography (UPLC) and validated through Gas Chromatography Mass Spectroscopy (GC-MS), Liquid Chromatography Mass Spectrometry (LC-MS) and Fourier Transform Infrared Spectroscopy (FTIR). The fungal isolate was able to degrade 99.42% of sulfamethoxazole at a concentration of 150 mg/l within 7 d. Three metabolic compounds were identified throughout the Sulfamethoxazole biodegradation process. The degradation pathway was shown to follow first order kinetics model according to the kinetics energy.</p>","PeriodicalId":8929,"journal":{"name":"Biotechnology Letters","volume":"47 1","pages":"23"},"PeriodicalIF":2.0000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Letters","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10529-025-03568-6","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Over the last few decades sulfonamides are being prescribed on a large scale for treating human beings and livestock. Contaminants of sulfonamide antibiotics are present in various environments and these residues can enter the food web, leading to health threat. The purpose of this study was to assess sulfamethoxazole degradation using a novel strain of Aspergillus sp. and demonstrates the degradation pathway of sulfamethoxazole. To the best of our knowledge, this marks the first detailed biodegradation pathway for Aspergillus sp. AJC4 proposed. The biodegradation pattern of sulfamethoxazole was assessed using High Performance Liquid Chromatography (UPLC) and validated through Gas Chromatography Mass Spectroscopy (GC-MS), Liquid Chromatography Mass Spectrometry (LC-MS) and Fourier Transform Infrared Spectroscopy (FTIR). The fungal isolate was able to degrade 99.42% of sulfamethoxazole at a concentration of 150 mg/l within 7 d. Three metabolic compounds were identified throughout the Sulfamethoxazole biodegradation process. The degradation pathway was shown to follow first order kinetics model according to the kinetics energy.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Biotechnology Letters 工程技术-生物工程与应用微生物

CiteScore

5.90

自引率

3.70%

发文量

108

审稿时长

1.2 months

期刊介绍： Biotechnology Letters is the world’s leading rapid-publication primary journal dedicated to biotechnology as a whole – that is to topics relating to actual or potential applications of biological reactions affected by microbial, plant or animal cells and biocatalysts derived from them. All relevant aspects of molecular biology, genetics and cell biochemistry, of process and reactor design, of pre- and post-treatment steps, and of manufacturing or service operations are therefore included. Contributions from industrial and academic laboratories are equally welcome. We also welcome contributions covering biotechnological aspects of regenerative medicine and biomaterials and also cancer biotechnology. Criteria for the acceptance of papers relate to our aim of publishing useful and informative results that will be of value to other workers in related fields. The emphasis is very much on novelty and immediacy in order to justify rapid publication of authors’ results. It should be noted, however, that we do not normally publish papers (but this is not absolute) that deal with unidentified consortia of microorganisms (e.g. as in activated sludge) as these results may not be easily reproducible in other laboratories. Papers describing the isolation and identification of microorganisms are not regarded as appropriate but such information can be appended as supporting information to a paper. Papers dealing with simple process development are usually considered to lack sufficient novelty or interest to warrant publication.